Simtuzumab

From WikiMD.com - Food, Medicine & Wellness Encyclopedia

Simtuzumab is an experimental drug that was under development by Gilead Sciences for the treatment of Idiopathic pulmonary fibrosis and Liver fibrosis. It is a monoclonal antibody that targets LOXL2, an enzyme that cross-links collagen and elastin in the extracellular matrix.

History[edit | edit source]

Simtuzumab was originally developed by Arresto Biosciences, which was acquired by Gilead Sciences in 2011. The drug entered Phase 2 clinical trials for the treatment of idiopathic pulmonary fibrosis and liver fibrosis in 2012. However, the trials were discontinued in 2016 due to lack of efficacy.

Mechanism of Action[edit | edit source]

Simtuzumab works by binding to LOXL2, an enzyme that is involved in the cross-linking of collagen and elastin in the extracellular matrix. By inhibiting this enzyme, the drug is thought to reduce fibrosis.

Clinical Trials[edit | edit source]

Simtuzumab has been tested in several clinical trials for the treatment of various fibrotic diseases. However, the results have been disappointing. In 2016, Gilead Sciences announced that it was discontinuing the development of the drug due to lack of efficacy in Phase 2 trials.

Future Development[edit | edit source]

Despite the disappointing results, research into the role of LOXL2 in fibrosis continues. It is hoped that future drugs targeting this enzyme will be more effective.

See Also[edit | edit source]

Stub icon
   This article is a monoclonal antibody–related stub. You can help WikiMD by expanding it!





WHO Rod.svg
This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia
WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Transform your life with W8MD's budget GLP1 injections in NYC from $125 and up biweekly

W8mdlogo.png
W8MD weight loss doctors team

W8MD offers a medical weight loss program NYC and a clinic to lose weight in Philadelphia. Our W8MD's physician supervised medical weight loss centers in NYC provides expert medical guidance, and offers telemedicine options for convenience.

Why choose W8MD?

Book Your Appointment

Start your NYC weight loss journey today at our NYC medical weight loss, and Philadelphia and visit Philadelphia medical weight loss Call (718)946-5500 for NY and 215 676 2334 for PA

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's NYC physician weight loss.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available. Call 718 946 5500.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD